User profiles for F.M. Marty
Francisco MartyBrigham and Women's Hospital – Dana-Farber Cancer Institute Verified email at partners.org Cited by 20147 |
Role of (1→ 3)-β-D-glucan in the diagnosis of invasive aspergillosis
FM Marty, S Koo - Medical mycology, 2009 - Taylor & Francis
Measurement of serum (1→3)-β-D-Glucan (BG) is an aid in the diagnosis of fungemia and
deep-seated mycoses, including invasive aspergillosis (IA). BG is present in the cell wall of …
deep-seated mycoses, including invasive aspergillosis (IA). BG is present in the cell wall of …
Early remdesivir to prevent progression to severe Covid-19 in outpatients
…, N Behenna-Renton, F Duff, FM Marty… - … England Journal of …, 2022 - Mass Medical Soc
Background Remdesivir improves clinical outcomes in patients hospitalized with moderate-to-severe
coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in …
coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in …
Infectious complications associated with immunomodulating biologic agents
The repertoire of monoclonal antibodies and other biologic therapies targeted at precise
components of the immune response continues to expand rapidly. In theory, these therapies …
components of the immune response continues to expand rapidly. In theory, these therapies …
Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation
…, SP Hammond, H Einsele, FM Marty - Blood …, 2018 - ashpublications.org
Patients treated with allogeneic hematopoietic cell transplantation (HCT) are at risk of
cytomegalovirus (CMV) reactivation and disease, which results in increased morbidity and mortality…
cytomegalovirus (CMV) reactivation and disease, which results in increased morbidity and mortality…
Remdesivir for 5 or 10 days in patients with severe Covid-19
Background Remdesivir is an RNA polymerase inhibitor with potent antiviral activity in vitro
and efficacy in animal models of coronavirus disease 2019 (Covid-19). Methods We …
and efficacy in animal models of coronavirus disease 2019 (Covid-19). Methods We …
[HTML][HTML] Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial
Importance Remdesivir demonstrated clinical benefit in a placebo-controlled trial in patients
with severe coronavirus disease 2019 (COVID-19), but its effect in patients with moderate …
with severe coronavirus disease 2019 (COVID-19), but its effect in patients with moderate …
[HTML][HTML] Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation
FM Marty, P Ljungman, RF Chemaly… - … England Journal of …, 2017 - Mass Medical Soc
Background Cytomegalovirus (CMV) infection remains a common complication after allogeneic
hematopoietic-cell transplantation. Letermovir is an antiviral drug that inhibits the CMV–…
hematopoietic-cell transplantation. Letermovir is an antiviral drug that inhibits the CMV–…
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
Background Mucormycosis is an uncommon invasive fungal disease with high mortality and
few treatment options. Isavuconazole is a triazole active in vitro and in animal models …
few treatment options. Isavuconazole is a triazole active in vitro and in animal models …
[HTML][HTML] Transmission of lymphocytic choriomeningitis virus by organ transplantation
Background In December 2003 and April 2005, signs and symptoms suggestive of infection
developed in two groups of recipients of solid-organ transplants. Each cluster was …
developed in two groups of recipients of solid-organ transplants. Each cluster was …
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants
To the Editor: The Food and Drug Administration (FDA) approved voriconazole for the treatment
of invasive aspergillosis partly on the basis of data published in a report in the Journal, 1 …
of invasive aspergillosis partly on the basis of data published in a report in the Journal, 1 …